Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

Spokane's Gestalt Diagnostics lands $7.5M in funding to enhance its AI tools for digital pathology, aiming to improve cancer ...

Q1 2025 Management View CEO Sujal Patel highlighted progress in advancing Nautilus' proteome analysis platform, focusing on ...

Mercedes-Benz has signed a new agreement with Luminar Technologies to develop and integrate its latest lidar product, Luminar ...

Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $31 million upfront, and up to $270 million in ...

Women’s healthcare has long been underserved when it comes to technological innovation. While advancements in digital ...

Please update us on what you’re doing now. It looks like you founded a new firm. Mr. Singh: I left Oppenheimer last year, after an 18-year career; 10 years on the sell side, and 15 total between buy- ...

Despite executing "perfectly," Octagon confronted a “scientific no-go,” CEO Isaac Stoner said in his LinkedIn post announcing ...

A Cambridge-based pharmaceutical company reported to the state that it is laying off close to a hundred employees.

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed ...

With $30 million in state grants, pharmaceutical giant Merck is building a factory to employ at least 375 at an old DuPont ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...